Intrinsic Value of S&P & Nasdaq Contact Us

Zosano Pharma Corporation ZSANQ OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
27/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ZSANQ

Zosano Pharma Corporation (ZSANQ) and trades at $0.00. The 52-week range is 1.0E-4-7.630114.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-0.27, annual revenue of $785K.

The stock has a beta of 3.08, operates in the Healthcare sector.

Trading Data
Current Price$0.00
52-Week Range1.0E-4-7.630114
Volume5.69K
Avg Volume (30D)11.17K
Beta (1Y)3.08
Company
Employees40
CEOSteven Lo
CountryUS
ExchangeOther OTC
CurrencyUSD
CUSIP98979H301
Income (Latest Year)
Revenue$785K
Gross Profit$-11K
EBITDA$-27.99M
Operating Income$-29.74M
Net Income$-30.11M
EPS$-0.27
EPS Diluted$-0.27
Shares Outstanding$112.06M
Balance Sheet (Latest Year)
Total Assets$48.39M
Current Assets$11.61M
Cash & ST Investments$11.04M
Total Liabilities$15.42M
Total Debt$9.48M
Net Debt$-1.56M
Total Equity$32.98M
Debt / Equity0.29
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message